The Current Haleon Charts The Path Ahead For Consumer Health Marler joined gsk in april, prior to the completion of haleon’s formal spinoff as a standalone company in july. today, she is the chief customer officer of haleon as it is forging ahead with a sole focus on consumer health at a time when the importance of health and wellness has come into focus during a global pandemic. It is the aggregation of otc, vitamins and dietary supplements (vds), sports nutrition, and weight management and wellbeing. purchase the haleon plc in consumer health global company profile as part of our consumer health research for march 2023. euromonitor international is the leading provider of strategic market research reports.
The Current Haleon Charts The Path Ahead For Consumer Health Since listing in july 2022, shares are up 11.34% ( 4.04% ytd), and down c. 8.3% down from its all time high of gbp 3.54 us$9.0 (april 2023). looking ahead i am moderately positive about future. Digestive health and other our digestive health brands have a strong heritage in treating heartburn and gastric discomfort. our product offerings in this category also include skin health and smokers’ health. 19% 58% haleon annual report and form 20 f 2022 3 stratelic report orporate overnance financiag statements other lnformation haleon at. Haleon (lse: hln) is a global leader in consumer health, with brands trusted by millions of consumers globally. the group employs over 22,000 people across 170 markets, who are united by haleon’s purpose to deliver better everyday health with humanity. haleon’s product portfolio spans five major categories oral health, pain relief. Haleon announced its first quarter earnings last month and the results are very solid considering the current macro backdrop. the company reported revenue of £2.99 billion, up 13.7% yoy (year.
Comments are closed.